Interactions of borderline personality disorder and mood disorders over 10 years

Journal of Clinical Psychiatry

Volumn 75, Issue 8, 2014, Pages 829-834

  Gunderson, John G ^a   Stout, Robert L ^b   Shea, M Trade ^c,d   Grilo, Carlos M ^e   Markowitz, John C ^f   Morey, Leslie C ⁱ   Sanislow, Charles ^g   Yen, Shirley ^d   Zanarini, Mary C ^a   Keuroghlian, Alex S ^a   McGlashan, Thomas H ^e   Skodol, Andrew E ^f,h  

^a MCLEAN HOSPITAL   (United States)

^b PACIFIC INSTITUTE FOR RESEARCH AND EVALUATION   (United States)

^c PROVIDENCE VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d BROWN UNIVERSITY   (United States)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^g WESLEYAN UNIVERSITY   (United States)

^h UNIVERSITY OF ARIZONA   (United States)

ⁱ TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MOOD STABILIZER;

ADULT; ARTICLE; BIPOLAR I DISORDER; BIPOLAR II DISORDER; BORDERLINE STATE; COMORBIDITY; CONTROLLED STUDY; DISEASE COURSE; DSM-IV; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MOOD DISORDER; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PSYCHOSOCIAL DISORDER; RELAPSE; RELIABILITY; REMISSION; ADOLESCENT; BIPOLAR DISORDER; FEMALE; MALE; MIDDLE AGED; MULTICENTER STUDY; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; RECURRENT DISEASE; TIME; YOUNG ADULT;

ADOLESCENT; ADULT; BIPOLAR DISORDER; BORDERLINE PERSONALITY DISORDER; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECURRENCE; REMISSION INDUCTION; TIME FACTORS; YOUNG ADULT;

EID: 84908328339     PISSN: 01606689     EISSN: 15552101     Source Type: Journal    
DOI: 10.4088/JCP.13m08972     Document Type: Article

References (55)

1. Stone M. Contemporary shift of the borderline concept from a subschizophrenic disorder to a subaffective disorder. Psychiatr Clin North Am. 1979;2:577-594.
2. Akiskal HS, Yerevanian BI, Davis GC, et al. The nosologic status of borderline personality: clinical and polysomnography study. Am J Psychiatry. 1985;142(2):192-198.
3. Paris J, Gunderson JG, Weinberg I. The interface between borderline personality disorder and bipolar spectrum disorders. Compr Psychiatry. 2007;48(2):145-154.
4. Skodol AE, Shea MT, Yen S, et al. Personality disorders and mood disorders: perspectives on diagnosis and classification from studies of longitudinal course and familial associations. J Pers Disord. 2010;24(1):83-108.
5. New AS. Triebwasser J, Charney DS. The case for shifting borderline personality disorder to Axis I. Biol Psychiatry. 2008;64(8):653-659.
6. Perugi G, Toni C, Travierso MC, et al. The role of cyclothymia in atypical depression: toward a data-based reconceptualization of the borderlinebipolar II connection. J Affect Disord. 2003;73(l-2):87-98.
7. Galione J, Zimmerman M. A comparison of depressed patients with and without borderline personality disorder: implications for interpreting studies of the validity of the bipolar spectrum. J Pers Disord. 2010;24(6):763-772.
8. Siever LJ, Davis KL. A psychobiological perspective on the personality disorders. Am J Psychiatry. 1991;148(12):1647-1658.
9. McGlashan TH, Grilo CM, Skodol AE, et al. The collaborative longitudinal personality disorders study: baseline Axis I/II and II/II diagnostic co-occurrence. Acta Psychiatr Scand. 2000;102(4):256-264.
10. Zanarini MC, Frankenburg FR, Dubo ED, et al. Axis I comorbidity of borderline personality disorder. Am J Psychiatry. 1998;155(12):1733-1739.
11. Akiskal HS. Subaffective disorders: dysthymic, cyclothymic and bipolar II disorders in the "borderline" realm. Psychiatr Clin North Am. 1981;4(l):25-46.
12. Cowdry RW, Gardner DL. Pharmacotherapy of borderline personality disorder: alprazolam, carbamazepine, trifluoperazine, and tranylcypromine. Arch Gen Psychiatry. 1988;45(2):111-119.
13. Klein D. Psychopharmacological treatment and delineation of borderline disorders. In: Hartocoilis P, ed. Borderline Personality Disorders: The Concept, the Syndrome, the Patient. New York, NY: International Universities Press; 1977:365-384.
14. White CN, Gunderson JG, Zanarini MC, et al. Family studies of borderline personality disorder: a review. Harv Rev Psychiatry. 2003;11(1):8-19.
15. Koenigsberg HW, Anwunah I, New AS, et al. Relationship between depression and borderline personality disorder. Depress Anxiety. 1999;10(4):158-167.
16. Bender DS, Dolan RT, Skodol AE, et al. Treatment utilization by patients with personality disorders. Am J Psychiatry. 2001;158(2):295-302.
17. Zanarini MC, Frankenburg FR, Hennen J, et al. Mental health service utilization by borderline personality disorder patients and Axis II comparison subjects followed prospectively for 6 years. J Clin Psychiatry. 2004;65(l):28-36.
18. Lieb K, Vollm B, Riicker G, et al. Pharmacotherapy for borderline personality disorder: Cochrane systematic review of randomized trials. Br J Psychiatry. 2010;196(1):4-12.
19. Mercer D, Douglass AB, Links PS. Meta-analyses of mood stabilizers, antidepressants and antipsychotics in the treatment of borderline personality disorder: effectiveness for depression and anger symptoms. J Pers Disord. 2009;23(2):156-174.
20. Silk KR, Feurino L III. Psychopharmacology of personality disorders. In: Widiger T, ed. The Oxford Handbook of Personality Disorders. London, UK: England Oxford University Press; 2012:713-726.
21. Borderline Personality Disorder: The NICE Guideline on Treatment and Management. Leicester, UK: The British Psychological Society 8c The Royal College of Psychiatrists; 2009.
22. Zimmerman M, Ruggero CJ, Chelminski I, et al. Psychiatric diagnoses in patients previously overdiagnosed with bipolar disorder. J Clin Psychiatry. 2010;71(1):26-31.
23. Gunderson JG, Shea MT, Skodol AE, et al. The Collaborative Longitudinal Personality Disorders Study: development, aims, design, and sample characteristics. J Pers Disord. 2000;14(4):300-315.
24. Skodol AE, Gunderson JG, Shea MT, et al. The Collaborative Longitudinal Personality Disorders Study (CLPS): overview and implications. J Pers Disord. 2005;19(5):487-504.
25. Shea MT, Stout RL, Yen S, et al. Associations in the course of personality disorders and Axis I disorders over time. J Abnorm Psychol. 2004;113(4):499-508.
26. Gunderson JG, Morey LC, Stout RL, et al. Major depressive disorder and borderline personality disorder revisited: longitudinal interactions. J Clin Psychiatry. 2004;65(8):1049-1056.
27. Gunderson JG, Stout RL, Sanislow CA, et al. New episodes and new onsets of major depression in borderline and other personality disorders.] Affect Disord. 2008; lll(l):40-45.
28. Gunderson JG, Weinberg I, Daversa MT, et al. Descriptive and longitudinal observations on the relationship of borderline personality disorder and bipolar disorder. Am J Psychiatry. 2006;163(7):1173-1178.
29. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994.
30. Zanarini MC, Frankenburg FR, Sickel AE, et al. The Diagnostic Interview for DSM-1V Personality Disorders (DIPD-IV). Belmont, MA: McLean Hospital; 1996.
31. First MB, Gibbon M, Spitzer RL, et al. Structured Clinical Interview for DSM-IV Axis I Disorders-Patient Version (SC1D-I/P). New York, NY: Biometrics Research Dept, New York State Psychiatric Institute; 1996.
32. Zanarini MC, Skodol AE, Bender D, et al. The Collaborative Longitudinal Personality Disorders Study: reliability of Axis I and II diagnoses. J Pers Duord. 2000;14(4):291-299.
33. Zanarini MC, Shea MT. The Diagnostic Interview for DSM-IV Personality Disorders-Follow-Along Version (DIPD-FAV). Belmont, MA: McLean Hospital; 1996.
34. Gunderson JG, Stout RL, McGlashan TH, et al. Ten-year course of borderline personality disorder: psychopathology and function from the Collaborative Longitudinal Personality Disorders Study. Arch Gen Psychiatry. 2011;68(8):827-837.
35. Keller MB, Lavori PW, Friedman B, et al. The Longitudinal Interval Follow-Up Evaluation: a comprehensive method for assessing outcome in prospective longitudinal studies. Arch Gen Psychiatry. 1987;44(6):540-548.
36. Katz MM, Merman GL. Introduction: overview of the clinical studies program. Am J Psychiatry. 1979;136(1):49-51.
37. Grilo CM, Sanislow CA, Gunderson JG, et al. Two-year stability and change of schizotypal, borderline, avoidant, and obsessive-compulsive personality disorders. J Consult Clin Psychol. 2004;72(5):767-775.
38. Keller MB, Shapiro RW, Lavori PW, et al. Recovery in major depressive disorder: analysis with the life table and regression models. Arch Gen Psychiatry. 1982;39(8):905-910.
39. Stout RL, Dolan R, Dyck I, et al. Course of social functioning after remission from panic disorder. Compr Psychiatry. 2001;42(6):441-447.
40. Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data. New York, NY: John Wiley & Sons; 2002.
41. Singer JD, Willett JB. Applied Longitudinal Data Analysis: Modeling Change and Event Occurrence. New York, NY: Oxford University Press; 2003.
42. Skodol AE, Grilo CM, Keyes KM, et al. Relationship of personality disorders to the course of major depressive disorder in a nationally representative sample. Am I Psychiatry. 2011;168(3):257-264.
43. Hadjipavlou G, Mok H, Yatham LN. Pharmacotherapy of bipolar II disorder: a critical review of current evidence. Bipolar Disord. 2004;6(l):14-25.
44. Benazzi F. Exploring aspects of DSM-IV interpersonal sensitivity in bipolar II. Affect Disord. 2000;60(l):43-46.
45. Neves FS, Malloy-Diniz LF, Correa H. Suicidal behavior in bipolar disorder: what is the influence of psychiatric comorbidities? J Clin Psychiatry. 2009;70(1):13-18.
46. Akiskal HS, Lemmi H. Clinical, neuroendocrine, and sleep EEG diagnosis of "unusual" affective presentations: a practical review. Psychiatr Clin North Am. 1983;6(l):69-83.
47. Goodman M, Chowdhury S, New A, et al. Depressive disorders in borderline personality disorder: phenomenology and biological markers. In: Choi-Kain L, ed. Borderline Personality and Mood Disorders: Comorbidity of Controversy. New York, NY; Springer Publishing: in press.
48. ∗D Project results: a comprehensive review of findings. Curr Psychiatry Rep. 2007;9(6):449-459.
49. McMain SF, Links PS, Gnam WH, et al. A randomized trial of dialectical behavior therapy versus general psychiatric management for borderline personality disorder. Am J Psychiatry. 2009;166(12):1365-1374.
50. Zimmerman M. Would broadening the diagnostic criteria for bipolar disorder do more harm than good? implications from longitudinal studies of subthreshold conditions. J Clin Psychiatry. 2012;73(4):437-443.
51. Gunderson JG, Links PL. Handbook of Good Psychiatric Management (GPM) for Borderline Patients. Arlington, VA; American Psychiatric Press; 2014.
52. Wnuk S, McMain S, Links PS, et al. Factors related to dropout from treatment in two outpatient treatments for borderline personality disorder. J Pers Disord. 2013;27(6):716-726.
53. Gunderson JG, Zanarini MC, Choi-Kain LW, et al. Family study of borderline personality disorder and its sectors of psychopathology. Arch Gen Psychiatry. 2011;68(7):753-762.
54. Distel MA, Willemsen G, Ligthart L, et al. Genetic covariance structure of the four main features of borderline personality disorder. J Pers Disord. 2010;24(4):427-444.
55. Kendler KS, Myers J, Reichborn-Kjennerud T. Borderline personality disorder traits and their relationship with dimensions of normative personality: a Webbased cohort and twin study. Acta Psychiatr Scand. 2011;123(5):349-359.